Press Releases

Home > Press Releases

Press Releases (Page 38)

ACT Foundation recognizes Amgen Canada with Community Champion Award

OTTAWA, Jan. 12, 2022 (GLOBE NEWSWIRE) -- The ACT Foundation is proud to present Amgen Canada with ACT’s Community Champion Award in celebration of Amgen’s 5-year anniversary as a National Health Partner to the Foundation. ACT is honoured to bestow this award to a National Health Partner for assisting the Foundation as it strives to reach its goal that would see every Canadian high school student graduate with the skills and... ❯❯❯

Sharps Compliance Announces Second Quarter Fiscal 2022 Conference Call and Webcast

HOUSTON, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) announced today that it will release its second quarter 2022 results for the period ended December 31, 2021, before the opening of the financial markets on Wednesday, January 26, 2022. A conference call and webcast will follow at 11:00 a.m. ET, in which management will discuss the Company’s financial results, key market initiatives and business... ❯❯❯

LifeLabs welcomes four new members to its board of directors

Toronto, Ontario, Jan. 10, 2022 (GLOBE NEWSWIRE) -- LifeLabs is pleased to share that four new individuals have joined its board of directors. The recently appointed board members possess a variety of exceptional experience and skills in the fields of health care, technology, and business operations. The new members include: Dr. Brendan Byrne, Founder and Medical Director of Wellness Garage: Brendan has been a physician and digital... ❯❯❯

Sienna Senior Living Inc. Provides Business Update and Announces Addition to its Board of Directors

MARKHAM, Ontario, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today provided an update on its operations and announced the appointment of Paul Boniferro to its Board of Directors. Operations Update In recent weeks, the Omicron variant has impacted Canadians from coast to coast and further highlighted the challenges faced by the healthcare sector across the country. ... ❯❯❯

Amedisys Announces Paul Kusserow’s Retirement as Chief Executive Officer and Appoints Chris Gerard as Chief Executive Officer Effective April 15, 2022

BATON ROUGE, La., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high acuity care services, today announced that Chairman and Chief Executive Officer (CEO) Paul Kusserow will retire as CEO on April 15th, 2022. Upon his retirement as CEO, Mr. Kusserow will continue to serve as Chairman of the Board of Directors, and current President and Chief Operating... ❯❯❯

SeaSpine Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results, Including Record Fourth Quarter 2021 Revenue

CARLSBAD, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the fourth quarter and full year 2021. Fourth Quarter and Full Year 2021 Financial Results (all revenue amounts are preliminary and unaudited) Fourth quarter 2021 global revenue is... ❯❯❯

Surgery Partners Reaffirms 2021 and 2022 Full Year Guidance; David T. Doherty to Assume Role of Chief Financial Officer on February 1, 2022

BRENTWOOD, Tenn., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Members of management of Surgery Partners, Inc. (NASDAQ: SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, will be meeting with investors today, January 10, 2022, as part of the 40th Annual J.P. Morgan Healthcare Conference, including a virtual presentation at 5:15 p.m. ET. Based on results through November 2021, the Company is... ❯❯❯

Press release Biocartis Group NV: BIOCARTIS MEETS 2021 KEY OBJECTIVES

PRESS RELEASE:  REGULATED INFORMATION10 January 2022, 07:00 CET BIOCARTIS MEETS 2021 KEY OBJECTIVES Mechelen, Belgium, 10 January 2022 - Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), announced the Company has achieved its 2021 key business objectives which were focused on three performance indicators: expanded installed base of its rapid and... ❯❯❯

Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection

SAN DIEGO, Jan. 09, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, and Queen Mary University of London, announced today the execution of a research collaboration and exclusive license agreement. The collaboration will focus on development and optimization of patent-pending precision medicine approaches, based on RNA expression signatures, to personalize therapeutic agent... ❯❯❯

Core One Labs Now Also Working to Biosynthesize DMT and Receives License

VANCOUVER, British Columbia, Jan. 08, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that it has progressed its work on biosynthesizing N,N-Dimethyltryptamine (“DMT”) and has been approved by Health Canada to add N,N-Dimethyltryptamine (“DMT”) to the schedule of approved controlled substances under the existing... ❯❯❯